Header Logo

Connection

Jamile Shammo to Chromosome Deletion

Back to Details
This is a "connection" page, showing publications Jamile Shammo has written about Chromosome Deletion.
Jamile Shammo
Connection Strength
0.019
Chromosome Deletion
  1. Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. Blood. 2008 Jan 01; 111(1):86-93.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.